A new round of generic drugs from China has been available online at a discount price for the first time in the country.
The drugs, which are currently in the clinical trials phase, are made up of the latest in a series of drugs approved by China’s national drug regulator, the National Health and Family Planning Commission.
The price cuts were announced on Wednesday and were the first in a long list of changes made by the commission in the run up to the next batch of drugs, the first of which will be approved by the country’s national pharmacists.
“We are very pleased to offer our customers the opportunity to purchase the products they need in their personal medicine cabinets at a reasonable price,” said Zhong Li, head of marketing at China’s drug regulator.
“We have always focused on making medicines more accessible for the Chinese people, so this is an important step towards this goal.”
One of the new drugs is a brand new version of the anti-nausea medication dutasteride, which has been approved by Chinese authorities for use in treating nausea in patients with HIV and hepatitis C. The drug was originally approved by regulators in 2012, but was delayed from being approved by doctors in China for several years, as the company was struggling to find a generic that would compete with the brand-name drugs.
The new version was made available for free at the start of the trial phase, but the price cuts came as no surprise.
“The new generic is much cheaper than the existing generic, and it’s the best price we have seen for a new product,” said Jia Zhang, director of global research and analytics at China Chemicals Institute.
“It’s also a lot more affordable than the generic that was approved for use on a daily basis in China in June 2017.”
China has seen a steep increase in the number of people with HIV/AIDS over the last few years, which the country has struggled with.
The country is expected to see the number increase to 5.3 million by 2021, up from 4.6 million in 2020, according to the United Nations.
The number of new infections has been falling steadily, and the country recently reported that more than 1 million people in the first two months of 2018 were living with HIV.
As the new batch is not in the drug regulator’s clinical trials, there are no official figures on the overall number of cases in China.
But the commission said that in the next two to three years, the country could see a significant increase in cases, with the rate of new HIV cases increasing by 50 percent over the next five years.
Currently, China is the world’s largest producer of generic anti-viral medicines, but there have been a number of issues with the drugs over the years.
One of the most controversial issues was the use of a synthetic form of dutasterein, a drug previously used in HIV treatments that has recently been used to make drugs for other diseases, such as liver cirrhosis.
Despite the criticism, the new version is an entirely new drug, so the company said it would work to improve the safety and efficacy of the drugs.
The new version also includes an improved version of a drug used for cancer treatment, which was previously made only available in China by a limited company.
For patients with a severe reaction to the drug, such a drug may be more effective than the current generic version.
In order to make sure the drug is safe and effective, the company will have to increase its manufacturing capacity and conduct further testing to ensure the new drug is the most effective.
If the price reductions go through, patients can expect to see a reduction in the amount of medicine they take every day, and they may also be able to get the drug sooner.
A spokesperson for the National Pharmacy Association in China told the BBC that it was “disappointed” to see drug prices dropping in China, but that it hopes the changes will “help drive better quality drug choices and patient care”.
“This new batch represents a significant improvement for the industry,” the spokesperson said.
“The new product is expected in the United States and Europe, and we are optimistic that this new batch will benefit patients around the world.”
In addition to the generic drugs, other generic drugs have also been approved for sale in China: The generic versions of several popular prescription drugs have been added to a new batch.
New batches of a number new generic drugs are available at discounted prices on Chinese drug websites.
While many people are taking generic drugs to treat nausea, the drug shortage has also put pressure on pharmacies to sell them at a lower price.
This is not the first case of a new drug being available for cheap.
Last year, the Chinese government introduced a new class of medicines called the “taiwan” class, which is intended to help people with a variety of diseases